MA28927B1 - Formulations de gel contenant 4-hydroxy tamoxifene - Google Patents

Formulations de gel contenant 4-hydroxy tamoxifene

Info

Publication number
MA28927B1
MA28927B1 MA29815A MA29815A MA28927B1 MA 28927 B1 MA28927 B1 MA 28927B1 MA 29815 A MA29815 A MA 29815A MA 29815 A MA29815 A MA 29815A MA 28927 B1 MA28927 B1 MA 28927B1
Authority
MA
Morocco
Prior art keywords
hydroxy tamoxifen
formulations containing
gel formulations
tamoxifen
hydroxy
Prior art date
Application number
MA29815A
Other languages
English (en)
Inventor
Valerie Masini-Eteve
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292447A external-priority patent/EP1647271A1/fr
Application filed by Besins Int Lab filed Critical Besins Int Lab
Publication of MA28927B1 publication Critical patent/MA28927B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA29815A 2004-10-14 2007-04-09 Formulations de gel contenant 4-hydroxy tamoxifene MA28927B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04292447A EP1647271A1 (fr) 2004-10-14 2004-10-14 Formulation sous forme de gel contenant 4-Hydroxy Tamoxifene.
US63835904P 2004-12-23 2004-12-23

Publications (1)

Publication Number Publication Date
MA28927B1 true MA28927B1 (fr) 2007-10-01

Family

ID=35501209

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29815A MA28927B1 (fr) 2004-10-14 2007-04-09 Formulations de gel contenant 4-hydroxy tamoxifene

Country Status (24)

Country Link
EP (1) EP1799201B1 (fr)
JP (1) JP5047800B2 (fr)
KR (1) KR101294947B1 (fr)
AT (1) ATE415156T1 (fr)
AU (1) AU2005293712B2 (fr)
BR (1) BRPI0518139B1 (fr)
CA (1) CA2582174C (fr)
CY (1) CY1110499T1 (fr)
DE (1) DE602005011314D1 (fr)
DK (1) DK1799201T3 (fr)
EA (1) EA011295B1 (fr)
ES (1) ES2318563T3 (fr)
GE (1) GEP20104889B (fr)
HK (1) HK1103027A1 (fr)
HR (1) HRP20090239T1 (fr)
IL (1) IL182298A (fr)
MA (1) MA28927B1 (fr)
MX (1) MX2007004371A (fr)
NO (1) NO338755B1 (fr)
PL (1) PL1799201T3 (fr)
PT (1) PT1799201E (fr)
SI (1) SI1799201T1 (fr)
TN (1) TNSN07139A1 (fr)
WO (1) WO2006040196A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR101304536B1 (ko) * 2011-06-03 2013-09-24 전남대학교산학협력단 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
JP4938237B2 (ja) * 2002-12-18 2012-05-23 ラボラトワール ブザン アンテルナスィヨナル ４−ヒドロキシタモキシフェンによる乳房痛の治療
EP1952809B1 (fr) * 2002-12-18 2017-08-02 Besins Healthcare Luxembourg SARL Formules pour la réduction de la densité du sein avec tamoxifène 4-hydroxy
JP5490346B2 (ja) * 2003-04-01 2014-05-14 ブザン ヘルスケア ルクセンブルグ エスアーエールエル ４−ヒドロキシタモキシフェンによる乳癌の予防および治療
JP5069469B2 (ja) * 2003-12-15 2012-11-07 ラボラトワール ブザン アンテルナスィヨナル 女性化乳房治療用の薬剤を製造する際の４−ヒドロキシタモキシフェンの使用
EP1579856A1 (fr) * 2004-03-22 2005-09-28 Laboratoires Besins International 4-Hydroxytamoxifène destiné au traitement des maladies bénignes des seins
AU2005227072B2 (en) * 2004-03-22 2010-08-19 Besins Healthcare Luxembourg Sarl Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
US20050208139A1 (en) * 2004-03-22 2005-09-22 Ascend Therapeutics, Inc. Chemically stable compositions of 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
EA011295B1 (ru) 2009-02-27
CA2582174C (fr) 2013-01-29
PL1799201T3 (pl) 2009-05-29
DE602005011314D1 (de) 2009-01-08
ES2318563T3 (es) 2009-05-01
GEP20104889B (en) 2010-02-10
EA200700834A1 (ru) 2007-10-26
AU2005293712B2 (en) 2011-04-21
EP1799201A1 (fr) 2007-06-27
DK1799201T3 (da) 2009-03-30
SI1799201T1 (sl) 2009-06-30
NO338755B1 (no) 2016-10-17
JP2008525316A (ja) 2008-07-17
KR20070068366A (ko) 2007-06-29
WO2006040196A1 (fr) 2006-04-20
BRPI0518139A (pt) 2008-10-28
NO20072463L (no) 2007-05-14
AU2005293712A1 (en) 2006-04-20
IL182298A0 (en) 2007-07-24
HK1103027A1 (en) 2007-12-14
PT1799201E (pt) 2009-02-26
ATE415156T1 (de) 2008-12-15
IL182298A (en) 2013-01-31
MX2007004371A (es) 2007-06-07
JP5047800B2 (ja) 2012-10-10
EP1799201B1 (fr) 2008-11-26
BRPI0518139B1 (pt) 2021-10-13
TNSN07139A1 (en) 2008-11-21
HRP20090239T1 (en) 2009-06-30
CA2582174A1 (fr) 2006-04-20
KR101294947B1 (ko) 2013-08-09
CY1110499T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
NO20091976L (no) Nye forbindelser
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
NO20076413L (no) Multisykliske forbindelser og fremgangsmater for deres anvendelse
ATE432067T1 (de) Embolie-teilchen
SE0301700D0 (sv) Novel compounds
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
TW200505875A (en) Novel compounds
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
EA200702253A1 (ru) Фармацевтическая композиция
EA201071075A1 (ru) Композиция кондиционирующего шампуня
DK1937669T3 (da) Nye benzopyranderivater som kaliumkanalåbnere
NO20055741D0 (no) Nye kjemiske forbindelser
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
NO20063293L (no) Farmasoytiske forbindelser
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
MEP34308A (en) Oral formulations of cladribine
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
EA200700023A1 (ru) Разрыхляющаяся при пероральном приёме фармацевтическая композиция, содержащая рисперидон
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
EA200501301A1 (ru) Ментоловые растворы лекарственных препаратов
ATE535251T1 (de) Stabile wässrige g-csf-haltige zusammensetzungen